CASP3 and episodic ataxia type 2: MMP1, IL-8, and caspase-3 protein levels in 20 patients suffering from CAPA and 45 control COVID-19 patients without Aspergillus infections were analyzed (in total 65 patients, 65 samples; Supplementary Table S2).